NASDAQ: XRAYDentsply Sirona Inc Stock
$12.83+0.18 (+1.42%)
Updated Apr 17, 2025
XRAY Price
$12.83
Fair Value Price
N/A
Market Cap
$2.55B
52 Week Low
$12.16
52 Week High
$31.00
P/E
-2.86x
P/B
1.31x
P/S
1.02x
PEG
N/A
Dividend Yield
3.74%
Revenue
$3.79B
Earnings
-$910.00M
Gross Margin
51.6%
Operating Margin
-22.86%
Profit Margin
-24%
Debt to Equity
1.96
Operating Cash Flow
$461M
Beta
0.9
Next Earnings
Apr 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
XRAY Overview
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XRAY's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
B
XRAY
Ranked#30 of 41
Ranked#30 of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $4.91 | A | |
| $90.89 | B | |
| $60.83 | B |
Be the first to know about important XRAY news, forecast changes, insider trades & much more!
XRAY News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XRAY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XRAY is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XRAY is good value based on its book value relative to its share price (1.31x), compared to the US Medical Instruments & Supplies industry average (3.55x)
P/B vs Industry Valuation
XRAY is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more XRAY due diligence checks available for Premium users.
Valuation
XRAY fair value
Fair Value of XRAY stock based on Discounted Cash Flow (DCF)
Price
$12.83
Fair Value
$39.18
Undervalued by
67.26%
XRAY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
XRAY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.86x
Industry
40.39x
Market
27.98x
XRAY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.31x
Industry
3.55x
XRAY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XRAY's financial health
Profit margin
Revenue
$905.0M
Net Income
-$430.0M
Profit Margin
-47.5%
XRAY's Earnings (EBIT) of -$867.00M... subscribe to Premium to read more.
Interest Coverage Financials
XRAY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.8B
Liabilities
$3.8B
Debt to equity
1.96
XRAY's short-term assets ($1.75B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XRAY's long-term liabilities ($2.22B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XRAY's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
XRAY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$87.0M
Investing
-$57.0M
Financing
-$38.0M
XRAY's operating cash flow ($461.00M)... subscribe to Premium to read more.
Debt Coverage Financials
XRAY vs Medical Stocks
Dentsply Sirona Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.